FDA NDC

Oxaprozin

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
70512-787
Proprietary name
Oxaprozin
Nonproprietary name
Oxaprozin
Labeler
SOLA Pharmaceuticals, LLC
Dosage form
CAPSULE
Strength
300 mg/1

Run it in Rivvi

Which 2027 plans near you dropped or restricted Oxaprozin?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.